Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived...
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18–49 years of age
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights•The production of biopharmaceuticals in plants is a rapidly expanding field. •A quadrivalent VLP influenza vaccine (QVLP) was produced in Nicotiana benthamiana. •The consistency of this novel platform was tested using the 2016–2017 QVLP vaccine. •Three QVLP lots elicited equivalent antibody responses to the targeted HA proteins. •The QVL...
Alternative Titles
Full title
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18–49 years of age
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2489605018
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2489605018
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2021.01.004
